製品の概要

  • 製品名
    AZD4547
  • 製品の詳細
    Novel, selective FGFR inhibitor
  • 別名
    • AZD-4547
  • 生理活性の詳細

    Novel, selective inhibitor of the FGFR1, 2, and 3 tyrosine kinases. Binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, thus resulting in the inhibition of tumor cell proliferation and tumor cell death. 

  • 精製度
    > 98%

製品の特性

  • 体系名

    N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide

  • 分子量
    463.57
  • 構造式
    Chemical Structure
  • 分子式
    C26H33N5O3
  • CAS 番号
    1035270-39-3
  • PubChem 登録番号
    51039095
  • 保存方法
    Shipped at 4°C. Store at -20°C. Store In the Dark. Store under desiccating conditions.
  • 溶解性

    DMSO (>80 mg/ml)

  • SMILES 線形表記
    O=C(Nc2cc(CCc1cc(OC)cc(OC)c1)nn2)c3ccc(cc3)N4C[C@H](C)N[C@H](C)C4

    AZD4547 (ab216311) 使用論文

    This product has been referenced in:
    • Kwak Y  et al. Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated Endometrial Cancer Cells. Mol Cancer Ther 14:2292-302 (2015). Read more (PubMed: 26294741) »
    • Doughton G  et al. Formation of a polarised primitive endoderm layer in embryoid bodies requires fgfr/erk signalling. PLoS One 9:e95434 (2014). Read more (PubMed: 24752320) »
    • Gavine PR  et al. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res 72:2045-56 (2012). Read more (PubMed: 22369928) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab216311.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

    登録